Fig. 2

A Receiver operating characteristic (ROC) curve analyses of integrative variables (age, hsCRP, infarct volume, GRASPS, FBG, self-transferring) to discriminate patients (without previous antiplatelet therapy) with poor functional outcome. Area under the ROC curve (AUC) for model 1, hsCRP rule in was 0.7133 (95% CI 0.6326–0.7895), and for model 2, hsCRP rule out was 0.7087 (95% CI 0.6335–0.7810). B ROC analyses of integrative variables (age, hsCRP, infarct volume, GRASPS, FBG, self-transferring) to discriminate patients (with previous antiplatelet therapy) with poor functional outcome. AUC for model 1, hsCRP rule in was 0.8724 (95% CI 0.5556–0.9302), and for model 2, hsCRP rule out was 0.7582 (95% CI 0.4767–0.9133)